Jamie Christensen - 07 Sep 2022 Form 4 Insider Report for Mirati Therapeutics, Inc.

Signature
/s/ Reena Desai, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
07 Sep 2022
Net transactions value
$0
Form type
4
Filing time
09 Sep 2022, 17:35:45 UTC
Previous filing
14 Jun 2022
Next filing
05 Dec 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Award $0 +19,149 +22% $0.000000 106,089 07 Sep 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents shares from a Performance Share Unit Award where the performance requirements were deemed as achieved by the Board of Director on 09/07/22. Shares will vest 25% annually on the anniversary of the goal achievement date until fully vested
F2 Includes 136 shares acquired under the ESPP Purchase on 5/31/22